ARES
Ares Management Corporation
There isn't enough reported data to score ARES yet.
JPM
JPMorgan Chase & Co.
JPM's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
ARES Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Stable | |
| N/A | |
| N/A |
ARES's profitability is currently stable. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like ARES.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
ARES PE Valuation
ARES has no meaningful PE right now: it lost money over the past year.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
ARES Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Strong growth | |
| Weakening | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for ARES, but weaker profitability.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
JPM has the edge over ARES on the outlook, with more favorable profitability expectations.
ARES Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.53 | +220% |
| Q4 2024 | $2.04 | -16% |
| Q3 2024 | $2.20 | +1.4% |
| Q2 2024 | $1.95 | +18% |
| Q1 2024 | $2.26 | +102% |
| Q4 2023 | $2.42 | +178% |
| Q3 2023 | $2.17 | +136% |
| Q2 2023 | $1.65 | +3.8% |
| Q1 2023 | $1.12 | -46% |
JPM has the stronger earnings trend. Trailing diluted EPS is down 16% for ARES versus JPM up 18%.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
ARES Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2024 | $1.2B | +11% |
| Q3 2024 | $842M | +24% |
| Q2 2024 | $874.9M | +11% |
| Q1 2024 | $735.8M | +13% |
| Q4 2023 | $1.1B | +0.7% |
| Q3 2023 | $677.7M | +12% |
| Q2 2023 | $785.1M | +28% |
| Q1 2023 | $653.7M | +18% |
ARES has the stronger quarterly revenue trend. Revenue is up 71% for ARES versus up 8.1% for JPM.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 19% | N/A |
| Q4 2024 | 32% | -11 points |
| Q3 2024 | 39% | +5.4 points |
| Q2 2024 | 36% | -12 points |
| Q1 2024 | 31% | -5.5 points |
| Q4 2023 | 43% | +12 points |
| Q3 2023 | 33% | +44 points |
| Q2 2023 | 49% | +38 points |
ARES's operating margin was 19% last quarter, down 12 points from the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over ARES on profitability, with a higher operating margin.
ARES Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | $807.6M | +$1.4B |
| Q3 2024 | $841.3M | +164% |
| Q2 2024 | $432.2M | +$1.1B |
| Q1 2024 | $710M | +0.3% |
| Q4 2023 | -$560.1M | -$369.5M |
| Q3 2023 | $318.3M | +1194% |
| Q2 2023 | -$699.1M | +$93.3M |
| Q1 2023 | $707.6M | +216% |
ARES has the stronger cash trend. Its trailing FCF is up 484% versus its history, compared with JPM at down 229%.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
ARES Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +15% | +47.1M shares |
| 1 year | +16% | +50.6M shares |
| 3 years | +23% | +66.9M shares |
| 5 years | +46% | +113M shares |
ARES has 360M diluted shares, up 16% from a year ago.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over ARES on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
ARES Net Leverage
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
ARES Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.0 | Neutral |
| Stochastic | 54.4 | Neutral |
ARES's weekly RSI is 54 (neutral) and its Stochastic is 54 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
ARES PE vs Financial Services Sector
| Metric | ARES | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
ARES has no meaningful PE right now: it lost money over the past year.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
ARES Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $123.3 | 8.1% above |
| 20 week MA | $128.3 | 3.9% above |
| 50 week MA | $130.7 | 2% above |
| 100 week MA | $148.9 | 10% below |
| 200 week MA | $134.3 | 0.7% below |
ARES has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 0.7% below its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over ARES on trend strength, trading above more of its moving averages.
ARES Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $34.8 | $49.1 | +41% |
| 2021 | $49.1 | $81.4 | +66% |
| 2022 | $81.4 | $67.7 | -17% |
| 2023 | $67.7 | $118.9 | +76% |
| 2024 | $118.9 | $179.5 | +51% |
| 2025 | $179.5 | $168.7 | -6% |
| 2026 YTD | $168.7 | $133.3 | -21% |
ARES has finished higher in four of the last six years, three of them by more than 50%. It's down 21% so far in 2026.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over ARES on returns for 2026, with the stronger performance.